UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036055
Receipt number R000041035
Scientific Title Efficacy of mouth breathing prevention tape during sleep in healthy adults: A randomized crossover study
Date of disclosure of the study information 2019/04/02
Last modified on 2020/10/07 18:17:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of mouth breathing prevention tape during sleep in healthy adults: A randomized crossover study

Acronym

Efficacy of mouth breathing prevention tape during sleep: A randomized crossover study

Scientific Title

Efficacy of mouth breathing prevention tape during sleep in healthy adults: A randomized crossover study

Scientific Title:Acronym

Efficacy of mouth breathing prevention tape during sleep: A randomized crossover study

Region

Japan


Condition

Condition

healthy

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine with crossover method whether mouth breathing prevention tape during sleep improves quality of sleep using sleep diary and smartphone sleep application.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

In the MBS (mouth breathing during sleep) group, we compare the PSQI (Pittsburgh Sleep Quality Index) total score in the sleep questionnaire and the assignment to the total sleeping time and the deep sleep time recorded by "Sleep Meister" with "refreshing feeling upon getting up", with or without.

Key secondary outcomes

We compare the PSQI total scores before, during and after the intervention, and the "refreshing feeling upon getting up" and the ratio of the deep sleep time recorded by "Sleep Meister" and the total sleeping time in the MBS group and the NBS (nasal breathing during sleep) group.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

For 7 days, the subject sticks a mouth breathing prevention tape and take a sleeps.

Interventions/Control_2

No treatment

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy 20-65 year old men and women
No obesity (BMI less than 30)

Key exclusion criteria

In case of nose blockage
When there is wound / rash on the lips and skin around the lips
When their lips and skin are fragile
When drugs are used regularly
In case of pregnancy

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Kenji
Middle name
Last name Tani

Organization

Tokushima University Hospital

Division name

Department of General Medicine and Primary Care

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan

TEL

088-633-9614

Email

taniken@tokushima-u.ac.jp


Public contact

Name of contact person

1st name Harutaka
Middle name
Last name Yamaguchi

Organization

Tokushima University Graduate School of Biomedical Sciences

Division name

Department of General Medicine

Zip code

770-8503

Address

3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan

TEL

088-633-9656

Homepage URL


Email

yharutaka@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima University

Institute

Department

Personal name



Funding Source

Organization

Non

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Center for Developmental Therapeutics, Tokushima University Hospital

Address

2-50-1 Kuramoto-cho, Tokushima 770-8503, Japan

Tel

088-633-9294

Email

awachiken@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

徳島大学(徳島県)


Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 03 Month 15 Day

Date of IRB

2019 Year 03 Month 25 Day

Anticipated trial start date

2019 Year 04 Month 02 Day

Last follow-up date

2019 Year 10 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 03 Month 01 Day

Last modified on

2020 Year 10 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041035


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name